Several years after approving the HPV vaccine for girls for the prevention of cervical cancer (and genital warts), and a couple after giving a lukewarm recommendation for boys, the Advisory Committee on Immunization Practices has made a recommendation for boys and young men to get the vaccine.
This is an important step, because some insurers do not pay for this vaccine for young men, even though they cover it for young women. Once the Center for Disease Control and Prevention (CDC) accepts this recommendation and publishes it officially (a 2 to 3 month process), insurance companies will be required to cover it as they do routine immunizations.
Here in Texas, we have been lucky because our state had the foresight to expand the federal Vaccines for Children program to include vaccination of “underinsured” individuals. So, many boys with otherwise good medical insurance, but not covering them this vaccine were able to get it through publicly funded programs. Budget cutting in Texas and elsewhere may soon make this option unavailable.
The discrepancy came primarily because the initial indicated use for the vaccine was to prevent cervical cancer. Although males and females have an equal burden of human papilloma virus infection, or HPV, and despite the fact that males help to spread the infection to females, males of course don’t have a cervix! They are just as prone to genital warts, however, and many physicians were in favor of immunizing them long before the vaccine was shown to have other benefits – the prevention of penile, anal and oral cancers among them.
Now the issue will be convincing parents and youth to be vaccinated. Immunization rates for HPV vaccine continue to lag behind the rates for other vaccines, mostly because of unfounded fears of serious side effects, and parental belief that their children are not at risk for this infection.
